RADICAVA®
RADICAVA® (Edaravone) is a prescription drug used for the treatment of Amyotrophic Lateral Sclerosis.
RADICAVA® is manufactured by Mitsubishi Tanabe.
Administration and Dosage:
Administration of RADICAVA® is initially 14 days of intravenous infusion followed by a 14-day drug-free period with subsequent treatment cycles being 10 days out of 14 of intravenous infusion, followed by 14 day drug free periods.
Indication:
RADICAVA® is indicated to treat:
- Amyotrophic Lateral Sclerosis
Common Side Effects:
The more common side effects of RADICAVA® include hypersensitivity (allergic) reactions and sulfite allergic reactions.
More information:
Please read the full Prescribing Information and Patient Information for RADICAVA® and discuss any questions you have with your doctor.
HAVE QUESTIONS?
We are happy to help!
